Applied Dna Sciences Inc (BNBX)

$2.76 +0.01 (0.36%)
Market Cap 12.41M
Revenue (ttm) 3.43M
Net Income (ttm) -6.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -203.79%
Debt to Equity Ratio 0.00
Volume 48,512
Avg Vol 1,681,914
Day's Range N/A - N/A
Shares Out 4.36M
Stochastic %K 10%
Beta 0.15
Analysts Hold
Price Target N/A

Company Profile

BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic...

Industry: Asset Management
Sector: Financial Services
Phone: 631 240 8800
Fax: 631 240 8900
Website: www.bnbx.io
Address:
50 Health Sciences Drive, Stony Brook, United States
SuperGreenToday
SuperGreenToday Jun. 9 at 5:40 PM
$BNBX
0 · Reply
Adriana88
Adriana88 Jun. 6 at 10:46 AM
$BNBX kinda need a lot more volume
1 · Reply
Evissamwohs
Evissamwohs Jun. 2 at 6:21 PM
$BNBX It cracks me up Crypto is literally stalling the entire market today! Plus it’s a new month and money managers are trying to confuse retail on whether June will be Bullish or Bearish!
0 · Reply
Evissamwohs
Evissamwohs Jun. 2 at 3:14 PM
$BNBX It’s dropping today because Crypto is down especially Bitcoin!
0 · Reply
isuckdic
isuckdic Jun. 2 at 1:23 PM
$BNBX stock is a such a loser
1 · Reply
isuckdic
isuckdic Jun. 2 at 1:23 PM
$BNBX lol well that didn’t last
0 · Reply
mightyshrimp
mightyshrimp Jun. 1 at 4:45 PM
$BNBX only down 99.9% now 😂. Thank god I didn’t buy much of this 💩
0 · Reply
isuckdic
isuckdic Jun. 1 at 3:17 PM
$BNBX it’s me bro it’s a dilution event coming
0 · Reply
SJDodge
SJDodge Jun. 1 at 3:06 PM
$BNBX - Every board has at least 1 major 🤡 - Who is it on this board?!?
0 · Reply
OneSmartBull
OneSmartBull Jun. 1 at 2:19 PM
$BNBX
0 · Reply
Latest News on BNBX
BNB Plus secures commitments for $4.1M in financing, initiates strategic review

2026-05-26T12:18:49.000Z - 21 days ago

BNB Plus secures commitments for $4.1M in financing, initiates strategic review

BNB Plus Corp. (BNBX) Secures Initial Commitments for $4.1M in Strategic Financing

May 26, 2026, 8:00 AM EDT - 21 days ago

BNB Plus Corp. (BNBX) Secures Initial Commitments for $4.1M in Strategic Financing

BNB Plus Quarterly report: Q2 2026

May 15, 2026, 7:00 AM EDT - 4 weeks ago

BNB Plus Quarterly report: Q2 2026

BNB Plus Transcript: EGM 2026

Apr 28, 2026, 11:00 AM EDT - 7 weeks ago

BNB Plus Transcript: EGM 2026

BNB Plus ‘continues to execute’ on operating initiatives amid strategic review

2026-04-23T11:20:28.000Z - 7 weeks ago

BNB Plus ‘continues to execute’ on operating initiatives amid strategic review

BNB Plus Corp. completes production of $1.2M LineaDNA order

2026-04-23T11:10:46.000Z - 7 weeks ago

BNB Plus Corp. completes production of $1.2M LineaDNA order

BNB Plus Corp. Completes Historic $1.2 Million LineaDNA™ Order

Apr 23, 2026, 7:00 AM EDT - 7 weeks ago

BNB Plus Corp. Completes Historic $1.2 Million LineaDNA™ Order

BNB Plus Corp. announces review of strategic alternatives

2026-04-20T11:29:30.000Z - 2 months ago

BNB Plus Corp. announces review of strategic alternatives

BNB Plus Corp. receives non-compliance notice from Nasdaq

2026-04-20T11:27:14.000Z - 2 months ago

BNB Plus Corp. receives non-compliance notice from Nasdaq

BNB Plus Corp. Announces Review of Strategic Alternatives to Maximize Shareholder Value

Apr 20, 2026, 7:00 AM EDT - 2 months ago

BNB Plus Corp. Announces Review of Strategic Alternatives to Maximize Shareholder Value

BNB Plus Proxy statement: Proxy filing

Mar 24, 2026, 8:00 AM EDT - 3 months ago

BNB Plus Proxy statement: Proxy filing

BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea™ IVT Platform

Mar 18, 2026, 8:00 AM EDT - 3 months ago

BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea™ IVT Platform

BNB Plus Proxy statement: Proxy Filing

Mar 12, 2026, 8:00 AM EDT - 3 months ago

BNB Plus Proxy statement: Proxy Filing

BNB Plus Corp. reports BNB token holdings valued at $10.7M as of February 23

2026-02-24T14:26:10.000Z - 4 months ago

BNB Plus Corp. reports BNB token holdings valued at $10.7M as of February 23

BNB Plus Corp. receives two new orders for LineaDNA

2026-02-24T14:21:48.000Z - 4 months ago

BNB Plus Corp. receives two new orders for LineaDNA

BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA™ from Genetic Medicine Developers

Feb 24, 2026, 7:00 AM EST - 4 months ago

BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA™ from Genetic Medicine Developers

BNB Plus Quarterly report: Q1 2026

Feb 12, 2026, 7:00 AM EST - 4 months ago

BNB Plus Quarterly report: Q1 2026

BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board Director

Feb 5, 2026, 8:00 AM EST - 4 months ago

BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board Director

BNB Plus Transcript: Fintech & DATS Investor Conference

Feb 4, 2026, 11:30 AM EST - 4 months ago

BNB Plus Transcript: Fintech & DATS Investor Conference

BNB Plus Transcript: Digital Asset Treasury Virtual Investor Conference

Jan 27, 2026, 1:00 PM EST - 5 months ago

BNB Plus Transcript: Digital Asset Treasury Virtual Investor Conference

BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th

Jan 27, 2026, 8:00 AM EST - 5 months ago

BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th

BNB Plus Corp. receives $1.2M order for LineaDNA

2026-01-05T13:15:27.000Z - 5 months ago

BNB Plus Corp. receives $1.2M order for LineaDNA

BNB Plus Corp. (BNBX) Receives $1.2M Accelerated LineaDNA™ Order

Jan 5, 2026, 8:01 AM EST - 5 months ago

BNB Plus Corp. (BNBX) Receives $1.2M Accelerated LineaDNA™ Order

BNB Plus Registration statement: Registration Filing

Dec 22, 2025, 7:00 AM EST - 6 months ago

BNB Plus Registration statement: Registration Filing

BNB Plus Annual report: Q4 2025

Dec 21, 2025, 6:00 PM EST - 6 months ago

BNB Plus Annual report: Q4 2025

BNB Plus Corp. ships largest single LineaDNA order

2025-12-18T13:11:13.000Z - 6 months ago

BNB Plus Corp. ships largest single LineaDNA order

BNB Plus Corp. (BNBX) Announces Largest Ever Shipment of LineaDNATM

Dec 18, 2025, 8:00 AM EST - 6 months ago

BNB Plus Corp. (BNBX) Announces Largest Ever Shipment of LineaDNATM

BNB Plus says LineaRx subsidiary expected to approach profitability in Q1 2026

2025-12-09T14:45:20.000Z - 6 months ago

BNB Plus says LineaRx subsidiary expected to approach profitability in Q1 2026

BNB Plus acquires 3,349 additional BNB tokens for approximately $3M

2025-12-09T14:40:29.000Z - 6 months ago

BNB Plus acquires 3,349 additional BNB tokens for approximately $3M

BNB Plus Provides BNB Treasury and Operational Updates

Dec 9, 2025, 8:00 AM EST - 6 months ago

BNB Plus Provides BNB Treasury and Operational Updates

Applied DNA chairperson Judy Murrah steps down, Josh Kruger to succeed

2025-11-17T13:26:36.000Z - 7 months ago

Applied DNA chairperson Judy Murrah steps down, Josh Kruger to succeed

Applied DNA Rebrands as BNB Plus Corp., Elects Josh Kruger as Chairman of the Board

Nov 17, 2025, 8:00 AM EST - 7 months ago

Applied DNA Rebrands as BNB Plus Corp., Elects Josh Kruger as Chairman of the Board

BNB Plus Proxy statement: Proxy Filing

Nov 17, 2025, 7:00 AM EST - 7 months ago

BNB Plus Proxy statement: Proxy Filing

BNB Plus Proxy statement: Proxy Filing

Nov 10, 2025, 7:00 AM EST - 7 months ago

BNB Plus Proxy statement: Proxy Filing

BNB Plus Registration statement: Registration Filing

Oct 30, 2025, 8:00 AM EDT - 8 months ago

BNB Plus Registration statement: Registration Filing

BNB Plus Proxy statement: Proxy Filing

Oct 30, 2025, 8:00 AM EDT - 8 months ago

BNB Plus Proxy statement: Proxy Filing

Applied DNA Sciences files to sell 18.73M shares of common stock for holders

2025-10-30T10:22:09.000Z - 8 months ago

Applied DNA Sciences files to sell 18.73M shares of common stock for holders

BNBX Launches Digital Asset Treasury Dashboard and Provides Corporate Update

Oct 28, 2025, 8:00 AM EDT - 8 months ago

BNBX Launches Digital Asset Treasury Dashboard and Provides Corporate Update

Applied DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 Million

Oct 22, 2025, 8:00 AM EDT - 8 months ago

Applied DNA Sciences Closes up to $58 Million Private Placement; Announces Initial BNB Holdings Valued at Over $17 Million

Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX' Reflecting Digital Asset Treasury Strategy

Oct 6, 2025, 8:00 AM EDT - 9 months ago

Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX' Reflecting Digital Asset Treasury Strategy

Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation

Sep 29, 2025, 3:08 PM EDT - 9 months ago

Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation

Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences

Sep 23, 2025, 8:30 AM EDT - 9 months ago

Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences

Applied DNA Reports Third Quarter Fiscal 2025 Financial Results

Aug 14, 2025, 4:10 PM EDT - 10 months ago

Applied DNA Reports Third Quarter Fiscal 2025 Financial Results

BNB Plus Quarterly report: Q3 2025

Aug 14, 2025, 4:00 PM EDT - 10 months ago

BNB Plus Quarterly report: Q3 2025

BNB Plus Earnings release: Q3 2025

Aug 14, 2025, 4:00 PM EDT - 10 months ago

BNB Plus Earnings release: Q3 2025

Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application

Jul 24, 2025, 9:00 AM EDT - 11 months ago

Applied DNA Announces New Follow-On LineaDNA Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application

Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements

Jul 7, 2025, 9:00 AM EDT - 1 year ago

Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements

Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx

Jun 30, 2025, 9:00 AM EDT - 1 year ago

Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward

Jun 17, 2025, 4:10 PM EDT - 1 year ago

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August

Jun 16, 2025, 9:00 AM EDT - 1 year ago

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025

May 29, 2025, 8:00 AM EDT - 1 year ago

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025

Applied DNA Reports Second Quarter Fiscal 2025 Financial Results

May 15, 2025, 4:05 PM EDT - 1 year ago

Applied DNA Reports Second Quarter Fiscal 2025 Financial Results

BNB Plus Earnings release: Q2 2025

May 15, 2025, 4:00 PM EDT - 1 year ago

BNB Plus Earnings release: Q2 2025

BNB Plus Quarterly report: Q2 2025

May 15, 2025, 4:00 PM EDT - 1 year ago

BNB Plus Quarterly report: Q2 2025

Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3

May 14, 2025, 11:30 AM EDT - 1 year ago

Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3

Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA

Apr 21, 2025, 9:00 AM EDT - 1 year ago

Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA

BNB Plus Proxy statement: Proxy Filing

Apr 15, 2025, 8:00 AM EDT - 1 year ago

BNB Plus Proxy statement: Proxy Filing

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

Apr 8, 2025, 9:00 AM EDT - 1 year ago

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

BNB Plus Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

BNB Plus Proxy statement: Proxy Filing

Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement

Apr 1, 2025, 9:45 AM EDT - 1 year ago

Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement

Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test

Mar 26, 2025, 9:00 AM EDT - 1 year ago

Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test

Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025

Mar 12, 2025, 8:00 AM EDT - 1 year ago

Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025

BNB Plus Earnings Call Transcript: Q1 2025

Feb 13, 2025, 4:30 PM EST - 1 year ago

BNB Plus Earnings Call Transcript: Q1 2025

BNB Plus Quarterly report: Q1 2025

Feb 13, 2025, 4:30 PM EST - 1 year ago

BNB Plus Quarterly report: Q1 2025

BNB Plus Earnings release: Q1 2025

Feb 13, 2025, 4:30 PM EST - 1 year ago

BNB Plus Earnings release: Q1 2025

Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress

Feb 13, 2025, 4:03 PM EST - 1 year ago

Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress

Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025

Feb 12, 2025, 12:00 PM EST - 1 year ago

Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025

Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14

Feb 11, 2025, 8:30 AM EST - 1 year ago

Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14

BNB Plus Proxy statement: Proxy Filing

Feb 11, 2025, 7:00 AM EST - 1 year ago

BNB Plus Proxy statement: Proxy Filing

Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates

Jan 10, 2025, 9:00 AM EST - 1 year ago

Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates

BNB Plus Registration statement: Registration Filing

Jan 10, 2025, 7:00 AM EST - 1 year ago

BNB Plus Registration statement: Registration Filing

Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter

Jan 8, 2025, 4:30 PM EST - 1 year ago

Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter

Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA

Dec 18, 2024, 9:00 AM EST - 1 year ago

Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

Dec 17, 2024, 4:05 PM EST - 1 year ago

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

BNB Plus Annual report: Q4 2024

Dec 16, 2024, 6:00 PM EST - 1 year ago

BNB Plus Annual report: Q4 2024

BNB Plus Earnings release: Q4 2024

Dec 16, 2024, 6:00 PM EST - 1 year ago

BNB Plus Earnings release: Q4 2024

Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out

Dec 16, 2024, 10:00 AM EST - 1 year ago

Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out

BNB Plus Proxy statement: Proxy Filing

Dec 10, 2024, 7:00 AM EST - 1 year ago

BNB Plus Proxy statement: Proxy Filing

BNB Plus Proxy statement: Proxy Filing

Dec 10, 2024, 7:00 AM EST - 1 year ago

BNB Plus Proxy statement: Proxy Filing

BNB Plus Registration statement: Registration Filing

Nov 19, 2024, 7:00 AM EST - 1 year ago

BNB Plus Registration statement: Registration Filing

BNB Plus Proxy statement: Proxy Filing

Nov 14, 2024, 7:00 AM EST - 1 year ago

BNB Plus Proxy statement: Proxy Filing

Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

Oct 30, 2024, 7:15 AM EDT - 1 year ago

Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

BNB Plus Transcript: Maxim Group’s 2024 Healthcare Virtual Summit

Oct 16, 2024, 12:50 PM EDT - 1 year ago

BNB Plus Transcript: Maxim Group’s 2024 Healthcare Virtual Summit

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

Oct 15, 2024, 10:30 AM EDT - 1 year ago

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit

Sep 17, 2024, 9:15 AM EDT - 1 year ago

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit

Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application

Sep 17, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application

Applied DNA Launches Mpox Clade I and Clade II Testing Service

Sep 11, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Launches Mpox Clade I and Clade II Testing Service

Applied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan

Sep 4, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan

Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I

Aug 23, 2024, 9:00 AM EDT - 1 year ago

Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I

BNB Plus Proxy statement: Proxy Filing

Aug 21, 2024, 8:00 AM EDT - 1 year ago

BNB Plus Proxy statement: Proxy Filing

BNB Plus Proxy statement: Proxy Filing

Aug 21, 2024, 8:00 AM EDT - 1 year ago

BNB Plus Proxy statement: Proxy Filing

Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I

Aug 19, 2024, 3:25 PM EDT - 1 year ago

Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I

BNB Plus Earnings Call Transcript: Q3 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

BNB Plus Earnings Call Transcript: Q3 2024

BNB Plus Quarterly report: Q3 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

BNB Plus Quarterly report: Q3 2024

BNB Plus Earnings release: Q3 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

BNB Plus Earnings release: Q3 2024

BNB Plus Slides: Q3 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

BNB Plus Slides: Q3 2024

Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results

Aug 8, 2024, 4:10 PM EDT - 2 years ago

Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results

Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024

Aug 7, 2024, 8:00 AM EDT - 2 years ago

Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024

BNB Plus Proxy statement: Proxy Filing

Aug 5, 2024, 8:00 AM EDT - 2 years ago

BNB Plus Proxy statement: Proxy Filing

CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit

Jul 29, 2024, 11:57 AM EDT - 2 years ago

CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit

Jul 29, 2024, 11:10 AM EDT - 2 years ago

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit

SuperGreenToday
SuperGreenToday Jun. 9 at 5:40 PM
$BNBX
0 · Reply
Adriana88
Adriana88 Jun. 6 at 10:46 AM
$BNBX kinda need a lot more volume
1 · Reply
Evissamwohs
Evissamwohs Jun. 2 at 6:21 PM
$BNBX It cracks me up Crypto is literally stalling the entire market today! Plus it’s a new month and money managers are trying to confuse retail on whether June will be Bullish or Bearish!
0 · Reply
Evissamwohs
Evissamwohs Jun. 2 at 3:14 PM
$BNBX It’s dropping today because Crypto is down especially Bitcoin!
0 · Reply
isuckdic
isuckdic Jun. 2 at 1:23 PM
$BNBX stock is a such a loser
1 · Reply
isuckdic
isuckdic Jun. 2 at 1:23 PM
$BNBX lol well that didn’t last
0 · Reply
mightyshrimp
mightyshrimp Jun. 1 at 4:45 PM
$BNBX only down 99.9% now 😂. Thank god I didn’t buy much of this 💩
0 · Reply
isuckdic
isuckdic Jun. 1 at 3:17 PM
$BNBX it’s me bro it’s a dilution event coming
0 · Reply
SJDodge
SJDodge Jun. 1 at 3:06 PM
$BNBX - Every board has at least 1 major 🤡 - Who is it on this board?!?
0 · Reply
OneSmartBull
OneSmartBull Jun. 1 at 2:19 PM
$BNBX
0 · Reply
isuckdic
isuckdic Jun. 1 at 12:57 PM
$BNBX piece of shit is having some volume but it won’t move fishy fishy
0 · Reply
isuckdic
isuckdic Jun. 1 at 10:47 AM
$BNBX devils of dilution and reverse spilt burning our capital for what?
0 · Reply
jeni1988
jeni1988 Jun. 1 at 9:56 AM
$BNBX JUST IN: Binance to allow conversion of US stocks to tokenized stocks on BNB blockchain.
0 · Reply
ThisWi11hurt
ThisWi11hurt May. 30 at 11:16 PM
$BNBX $BNB.X looks good
0 · Reply
jeni1988
jeni1988 May. 30 at 8:16 PM
$BNBX Binance token is under 🔥🔥🔥 Lets see this POS at Monday
0 · Reply
Evissamwohs
Evissamwohs May. 29 at 10:28 PM
$BNBX This never trades much in extended hours except today! I’m keeping an eye on this.
0 · Reply
isuckdic
isuckdic May. 29 at 2:04 PM
$BNBX piece of shit company that never moves
0 · Reply
Evissamwohs
Evissamwohs May. 29 at 3:25 AM
$BNBX There was a bit of unusual price movement today.
1 · Reply
Eliertk
Eliertk May. 29 at 12:26 AM
$BNBX $BNBX Does management know profit has a + sign and not a minus -? Thank you management for retuning me so much value! What a pleasure! WASTED MONEY!
1 · Reply
Evissamwohs
Evissamwohs May. 28 at 2:04 PM
$BNBX Was that dilution this morning anyone know?
1 · Reply
isuckdic
isuckdic May. 28 at 1:32 PM
$BNBX piece of shit company
0 · Reply
isuckdic
isuckdic May. 28 at 11:16 AM
$BNBX 1.5 million trades without a price move higher its a pure scam stoxk
0 · Reply